Knowledge Hub · Saxsons Shielded Syringe Carrier
Per-syringe transport from the hot-lab dispense bench to the patient injection room takes 1–3 minutes. Across a 25–40-dose shift, the cumulative hand-time near dispensed radiopharmaceutical activity is the largest single contributor to operator extremity-dose budget at the bench → injection-room workflow boundary. This page is the physics behind the Pb-tier choice, the β-γ Perspex / acrylic hybrid construction for pure-beta isotopes, and the ALARA-distance + multi-syringe-ferry workflow design.
Why this matters
Why a separate transport shield
A dispensed unit-dose syringe is held in the operator hand from the hot lab to the patient injection room — typically 10–60 metres of walking, 1–3 minutes per dose. Dose-rate at the syringe surface depends on activity and isotope; cumulative extremity exposure across a 25–40-dose shift accumulates measurably. A shielded carrier is the engineered intervention that keeps the hand at maximum distance from the syringe well and adds a Pb wall between the operator hand and the source.
Lead attenuation at the dispense-energy range
At 140 keV (Tc-99m), the half-value layer in lead is ~ 0.27 mm — a 3 mm carrier wall delivers ~ 11 HVL (> 99.95 % attenuation). At 511 keV (FDG / Ga-68 / Cu-64), the HVL is ~ 4.1 mm — a 6 mm wall delivers ~ 1.5 HVL (~ 65 % attenuation); the 6 + 12 mm lateral variant (6 mm front/back + 12 mm laterally) delivers ~ 3 HVL on the lateral wall (~ 88 %) because that is the wall closest to the operator hand during carry. The 12 mm-all-sides premium tier delivers ~ 3 HVL on every side — the right tier when the operator hand is in any position relative to the chassis.
Source: NIST XCOM photon-attenuation cross-section database; NCRP Report 49 HVL framework.
β-γ hybrid physics (Pb + Perspex)
Pure-beta isotopes (Y-90 microspheres for SIR-T, P-32 for myeloproliferative work, Sr-89 for bone-pain palliation) generate bremsstrahlung X-rays when they stop in a high-Z absorber like lead. A Perspex (PMMA) or acrylic inner sheet stops the beta at low Z before it reaches the lead inner surface — eliminating the bremsstrahlung source. The lead behind the Perspex still handles the residual photon contribution and any incident gamma. This is the standard radiation-safety construction for any β-γ transport surface, including the Lu-177 PRRT carrier with its β contribution.
Source: NCRP Report 49 — beta-shielding chapter; IAEA Safety Reports Series No. 38.
ALARA distance principle at the transport step
Dose-rate falls with the square of distance from a point source. The long-handle design on the Saxsons carriers adds 200–300 mm between the operator hand and the shielded syringe well — at typical FDG unit-dose activity, that distance reduction translates to roughly 4× lower dose-rate at the hand vs a short-handle build with the same lead thickness. The ALARA "distance" principle is multiplicative with the "shielding" principle; the carrier optimises both.
Multi-syringe ferry vs single-syringe
Every hot-lab-to-injection-room round-trip exposes the operator to the dispensed-dose chain twice — once on the way out, once on the way back to pick up the next. A multi-syringe carrier ferries 2–4 dispensed unit doses per trip. For a 30-dispense shift, that reduces from 30 round-trips to ~ 8 — a substantial cumulative annual reduction in transport-step exposure across a 100-shift year. The multi-syringe slot pattern also rationalises the operator hand-time at the bench end (dispense, load slot, walk, deliver slot, walk back) instead of repeating per syringe.
AERB framework for in-facility transport
AERB Safety Code for Nuclear Medicine Facility governs radioactive-material movement between rooms inside a licensed nuclear-medicine facility, including the hot-lab-to-injection-room transport step. The shielded-carrier spec is part of the AERB licence-renewal documentation. The Saxsons per-batch lead-thickness certificate satisfies the regulator-audit point.
Source: AERB Safety Code for Nuclear Medicine Facility; ICRP Publication 103.
AERB, AAPM, ICRP, IAEA, NCRP and NIST anchoring the carrier-tier choice.
Indian regulatory framework — in-facility transport-shielding expectations.
AAPM radiopharmacy QC framework including operator-protection workflow.
Current ICRP framework defining the 20 mSv/year average and 500 mSv/year extremity-dose limits.
IAEA framework — operator protection at dispense + transport + injection steps.
HVL / TVL framework + beta-shielding chapter for the β-γ hybrid build.
Authoritative reference for photon attenuation coefficients across the SPECT / PET energy range.